Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
9.35
+0.13 (1.41%)
Mar 14, 2025, 11:33 AM EDT - Market open

Intellia Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-519.02-481.19-474.19-267.89-134.23
Upgrade
Depreciation & Amortization
10.298.987.576.896.31
Upgrade
Loss (Gain) From Sale of Assets
-0.080.07-0.16-0.04
Upgrade
Asset Writedown & Restructuring Costs
--55.99--
Upgrade
Loss (Gain) From Sale of Investments
-6.22-19.2715.4110.540.54
Upgrade
Loss (Gain) on Equity Investments
-15.6311.081.33-
Upgrade
Stock-Based Compensation
154.27134.0591.447.0119.9
Upgrade
Other Operating Activities
-0.113.49--
Upgrade
Change in Accounts Receivable
27.94-32.69-1.740.12.49
Upgrade
Change in Accounts Payable
6.82.52-4.580.535.06
Upgrade
Change in Unearned Revenue
-22.08-2.78-63.46-31.3645.12
Upgrade
Change in Other Net Operating Assets
-0.79-19.5115.917.824.86
Upgrade
Operating Cash Flow
-348.88-394.09-333.29-225.03-49.91
Upgrade
Capital Expenditures
-5.78-13.99-13.56-12.76-3.59
Upgrade
Sale of Property, Plant & Equipment
--0.15--
Upgrade
Sale (Purchase) of Intangibles
---44.83--
Upgrade
Investment in Securities
131.35-17.36218.55-538.02-210.9
Upgrade
Investing Cash Flow
125.57-31.35160.31-550.78-214.49
Upgrade
Issuance of Common Stock
185.75130.32582.96736.69371.78
Upgrade
Financing Cash Flow
185.75130.32582.96736.69371.78
Upgrade
Net Cash Flow
-37.57-295.11409.98-39.12107.38
Upgrade
Free Cash Flow
-354.66-408.07-346.85-237.79-53.5
Upgrade
Free Cash Flow Margin
-612.78%-1124.94%-665.46%-719.41%-92.25%
Upgrade
Free Cash Flow Per Share
-3.59-4.60-4.51-3.35-0.96
Upgrade
Levered Free Cash Flow
-133.38-268.21-256.18-69.57-43.46
Upgrade
Unlevered Free Cash Flow
-133.38-268.21-256.18-69.57-43.46
Upgrade
Change in Net Working Capital
-41.7675.1910.41-56.69-19.28
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.